focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksItaconix Plc Regulatory News (ITX)

Share Price Information for Itaconix Plc (ITX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 157.50
Bid: 155.00
Ask: 160.00
Change: 17.50 (12.50%)
Spread: 5.00 (3.226%)
Open: 141.50
High: 157.50
Low: 141.50
Prev. Close: 140.00
ITX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Marketing approval of nicotine gum in Europe

20 Nov 2013 07:00

RNS Number : 4427T
Revolymer PLC
20 November 2013
 



20th November, 2013

Revolymer plc

Revolymer files for marketing approval of its nicotine gum in Europe

Revolymer plc ("Revolymer" or the "Company"), the British polymer technology company, is pleased to announce that, on the 19th November 2013, its wholly-owned UK operating subsidiary Revolymer (U.K.) Limited filed for marketing authorisation in Europe of its proprietary nicotine gum products by submitting an application under Directive 2001/83/EC to the Medicines and Healthcare products Regulatory Agency (MHRA).

If approved, such authorisation will permit the marketing of Revolymer's 2mg and 4mg strength nicotine gum in the UK, Ireland, Poland and Spain. These countries are expected to be the first in Europe where Revolymer's nicotine gum products will be sold. Revolymer has already established a supply and distribution agreement for its nicotine gum in Poland, and aims to conclude commercialisation deals in the UK, Ireland and Spain in due course. The Company also plans to apply for marketing authorisations for additional countries in Europe as it establishes appropriate commercial pathways.

Roger Pettman, Chief Executive of Revolymer said: "I am pleased that our strategy to commercialise our nicotine gum products in Europe is progressing, as demonstrated by the achievement of this latest milestone. We believe that not only is our product bioequivalent to the existing reference product in Europe, but that it has additional benefits that consumers will value, namely a more confectionery-like chew."

The establishment of further nicotine gum commercialisation deals in Europe and the filing for regulatory approval of its nicotine gum in the US are expected to be the subject of future announcements by the Company.

 

Ends

 

For further information please contact:

 

Revolymer plc

+44 (0) 1244 283 500

Roger Pettman

Rob Cridland

 

 

Panmure Gordon (UK) Limited

+44 (0) 20 7886 2500

Callum Stewart / Adam James (Corporate Finance)

Adam Pollock / Charles Leigh-Pemberton (Corporate Broking)

 

Citigate Dewe Rogerson

+44 (0)20 7282 2945

David Dible / Ginny Pulbrook/Malcolm Robertson

 

 

 

About Revolymer

Revolymer is a technology company that designs, develops and formulates novel polymers to improve the performance of existing consumer products within the fast moving consumer goods (FMCG) and other industrial markets. Revolymer aims to generate significant and growing high quality revenue streams by licensing its unique technologies to manufacturers and marketers within these markets. Potential applications for the business's technologies are in the household products, personal care and coatings & adhesives product areas (together "Consumer Specialties") and in medicated chewing gum (including nicotine gum) and confectionery chewing gum (together "Gum").

www.revolymer.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCKMMMMKLDGFZM
Date   Source Headline
16th Aug 20199:00 amRNSPrice Monitoring Extension
6th Aug 20194:50 pmRNSHolding(s) in Company
5th Aug 20197:00 amRNSPDMR Shareholding
2nd Aug 20192:05 pmRNSSecond Price Monitoring Extn
2nd Aug 20192:00 pmRNSPrice Monitoring Extension
2nd Aug 201911:05 amRNSSecond Price Monitoring Extn
2nd Aug 201911:00 amRNSPrice Monitoring Extension
29th Jul 20196:03 pmRNSBlock listing Interim Review
19th Jul 20193:28 pmRNSResult of AGM
17th Jul 20197:00 amRNSHalf-Year Trading Update
10th Jul 20194:41 pmRNSSecond Price Monitoring Extn
10th Jul 20194:35 pmRNSPrice Monitoring Extension
9th Jul 20195:19 pmRNSHolding(s) in Company
27th Jun 20197:00 amRNSPreliminary Results
14th Jun 20197:00 amRNSNotice of Results
29th May 20197:00 amRNSSale of Minority Interest in Alkalon
21st May 20197:00 amRNSFirst personal care purchase order from Nouryon
20th May 20197:00 amRNSBoard Change
3rd May 20197:00 amRNSFirst European Order for New Detergent Polymer
2nd Apr 20194:41 pmRNSSecond Price Monitoring Extn
2nd Apr 20194:35 pmRNSPrice Monitoring Extension
28th Feb 20192:05 pmRNSSecond Price Monitoring Extn
28th Feb 20192:00 pmRNSPrice Monitoring Extension
28th Feb 20199:00 amRNSPersonal care agreement with Nouryon
18th Feb 201911:06 amRNSSecond Price Monitoring Extn
18th Feb 201911:00 amRNSPrice Monitoring Extension
18th Feb 20197:00 amRNSFull Year Trading Update
15th Jan 20194:40 pmRNSSecond Price Monitoring Extn
15th Jan 20194:35 pmRNSPrice Monitoring Extension
15th Jan 20199:00 amRNSDetergent polymer agreement with Nouryon
9th Jan 20192:20 pmRNSBlock listing Interim Review
5th Dec 20187:00 amRNSNew Licence Agreement with New Wave
26th Oct 20187:00 amRNSDirectorate Change
2nd Oct 20187:00 amRNSBoard Changes
27th Sep 20187:00 amRNSInterim results
9th Aug 20181:41 pmRNSResult of AGM
6th Aug 20187:00 amRNSAppointment of Interim Chief Financial Officer
3rd Aug 20188:51 amRNSDirector/PDMR Dealings
3rd Aug 20188:47 amRNSBoard Changes
2nd Aug 201812:49 pmRNSExercise of Options, Directors' Dealing & TVR
2nd Aug 201811:57 amRNSResult of General Meeting
1st Aug 201810:02 amRNSResult of Open Offer & US Additional Subscription
16th Jul 20187:30 amRNSRestoration - Itaconix plc
13th Jul 20183:58 pmRNSReplacement re Further Details on the Fundraising
13th Jul 20183:54 pmRNSBlock listing Interim Review
13th Jul 20183:26 pmRNSRestoration of Trading
13th Jul 201812:11 pmRNSPosting of Circular & Annual Report & Notice of GM
12th Jul 20184:47 pmRNSFurther Details on the Fundraising
12th Jul 20187:05 amRNSProposed Fundraising
12th Jul 20187:00 amRNSPreliminary Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.